VISA classification for graves orbitopathy

Ophthalmic Plastic and Reconstructive Surgery

Volumn 22, Issue 5, 2006, Pages 319-324

  Dolman, Peter J ^a,b   Rootman, Jack ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Vancouver General Hospital Eye Care Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; STEROID;

CHEMOSIS; CONJUNCTIVA; DECOMPRESSION SURGERY; DISEASE CLASSIFICATION; ENDOCRINE OPHTHALMOPATHY; EYE INFLAMMATION; EYE SURGERY; EYELID; EYELID EDEMA; HUMAN; MORTALITY; PRIORITY JOURNAL; PRISM; RATING SCALE; SCORING SYSTEM; SHORT SURVEY; STRABISMUS; VISA CLASSIFICATION; VISION;

GRAVES OPHTHALMOPATHY; HUMANS; SEVERITY OF ILLNESS INDEX; STRABISMUS; VISUAL ACUITY;

EID: 33748945035     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iop.0000235499.34867.85     Document Type: Short Survey

References (6)

1. Bartley GB. Evolution of classification systems for Graves' ophthalmopathy. Ophthal Plast Reconstr Surg 1995;11:229-37.
2. Werner SC. Classification of the eye changes of Graves' disease. Am J Ophthalmol 1969;68:646-8.
3. Bahn RS, Gorman CA. Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy. Endocrinol Metab Clin North Am 1987;16:391-407.
4. Mourits MP, Koornneef L, Wiersinga WM, et al. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol 1989;73:639-44.
5. Pinchera A, Wiersinga W, Glinoer D, et al. Classification of eye changes of Graves' disease. Thyroid 1992;2:235-6.
6. Gorman CA, Garrity JA, Fatourechi V, et al. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology 2001;108:1523-34.